ctrl K

Price Alert

XTL Biopharmaceuticals Lt... (XTLB)

NASDAQ: XTLB · Real-Time Price · USD

1.33

-0.09 (-6.34%)

At close: Aug 15, 2025, 1:40 PM

1.41

6.02%

After-hours: Aug 15, 2025, 04:00 PM EDT

XTL Biopharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	371K	1.4M	2.09M	2.97M
Short-Term Investments	772K	605K	1.63M	3.16M
Long-Term Investments	14K	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a
Receivables	99K	n/a	71K	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	47K	11K	14K	16K
Total Current Assets	1.34M	2.05M	3.81M	6.24M
Property-Plant & Equipment	187K	n/a	n/a	1K
Goodwill & Intangibles	7.01M	380K	380K	380K
Total Long-Term Assets	7.21M	380K	380K	381K
Total Assets	8.55M	2.43M	4.19M	6.62M
Account Payables	196K	1K	2K	2K
Deferred Revenue	18K	n/a	n/a	n/a
Short-Term Debt	138K	n/a	n/a	n/a
Other Current Liabilities	1.33M	n/a	n/a	n/a
Total Current Liabilities	2.21M	206K	187K	231K
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	689K	n/a	n/a	1.05M
Total Long-Term Liabilities	908K	n/a	n/a	1.05M
Total Liabilities	3.12M	206K	187K	1.28M
Total Debt	138K	n/a	n/a	n/a
Common Stock	23.14M	14.12M	14.12M	14.12M
Retained Earnings	-159.01M	-158.25M	-156.47M	-155.13M
Comprehensive Income	20K	20K	20K	20K
Shareholders Equity	5.43M	2.22M	4M	5.33M
Total Investments	786K	605K	1.63M	3.16M